Long-term safety of continuous levodopa/carbidopa infusion with ND0612: Results from the ongoing BeyoND study

被引：0
|
作者：
Poewe, W. [1 ]
Stocchi, F. [2 ]
Sopromadze, S. [3 ]
Adar, L. [3 ]
Sasson, N. [3 ]
Yardeni, T. [3 ]
Giladi, N. [4 ]
机构：
[1] Med Univ Innsbruck, Innsbruck, Austria
[2] Univ & Inst Res & Med Care IRCCS San Raffaele, Rome, Italy
[3] NeuroDerm, Rehovot, Israel
[4] Tel Aviv Univ, Neurol Inst, Tel Aviv Med Ctr, Sackler Sch Med,Sagol Sch Neurosci, Tel Aviv, Israel
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2022年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPR-017
引用
收藏
页码：181 / 181
页数：1
相关论文
共 50 条
  • [31] Pharmacokinetic and safety characterisation of carbidopa/levodopa subcutaneous infusion (ND0612): Phase I studies in healthy volunteers and patients with fluctuating Parkinson's disease
    Lewitt, P.
    Caraco, Y.
    Adar, L.
    Oren, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 514 - 514
  • [32] Pharmacokinetic profile of ND0612 (levodopa/carbidopa for subcutaneous infusion) in Parkinson's disease (PD) patients with motor fluctuations: results of a phase IIa dose finding study
    Giladi, N.
    Caraco, Y.
    Gurevich, T.
    Djaldetti, R.
    Cohen, Y.
    Yacobi-Zeevi, O.
    Oren, S.
    Kieburtz, K.
    Olanow, C. W.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 66 - 66
  • [33] Long-term safety and effectiveness of levodopa-carbidopa intestinal gel infusion
    De Fabregues, Oriol
    Dot, Joan
    Abu-Suboh, Monder
    Hernandez-Vara, Jorge
    Ferre, Alex
    Romero, Odile
    Ibarria, Marta
    Luis Seoane, Jose
    Raguer, Nuria
    Puiggros, Carolina
    Rosa Gomez, Maria
    Quintana, Manuel
    Ramon Armengol, Josep
    Alvarez-Sabin, Jose
    BRAIN AND BEHAVIOR, 2017, 7 (08):
  • [34] Quality of Life with 24-hour Subcutaneous Levodopa/Carbidopa Infusion (ND0612): PDQ-39 Results from a Phase 3 Randomized Active-Controlled Study
    Sarva, H.
    Tagliati, M.
    Poewe, W.
    Stocchi, F.
    Rascol, O.
    Yardeni, T.
    Lopes, N.
    Pereira, J.
    Espay, A.
    MOVEMENT DISORDERS, 2024, 39 : S298 - S298
  • [35] ND0612 (levodopa/carbidopa for subcutaneous infusion) in patients with Parkinson's disease and motor response fluctuations: A randomized, placebo-controlled phase 2 study
    Giladi, Nir
    Gurevich, Tanya
    Djaldetti, Ruth
    Adar, Liat
    Case, Ryan
    Leibman-Barak, Shelly
    Sasson, Nissim
    Caraco, Yoseph
    PARKINSONISM & RELATED DISORDERS, 2021, 91 : 139 - 145
  • [36] Long-term experience with continuous duodenal levodopa–carbidopa infusion (Duodopa): report of six patients
    F. Raudino
    P. Garavaglia
    C. Pianezzola
    G. Riboldazzi
    S. Leva
    M. Guidotti
    G. Bono
    Neurological Sciences, 2009, 30 : 85 - 86
  • [37] Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial
    Espay, Alberto J.
    Stocchi, Fabrizio
    Pahwa, Rajesh
    Albanese, Alberto
    Ellenbogen, Aaron
    Ferreira, Joaquim J.
    Giladi, Nir
    Gurevich, Tanya
    Hassin-Baer, Sharon
    Hernandez-Vara, Jorge
    Isaacson, Stuart H.
    Kieburtz, Karl
    Lewitt, Peter A.
    Lopez-Manzanares, Lydia
    Olanow, C. Warren
    Poewe, Werner
    Sarva, Harini
    Yardeni, Tami
    Adar, Liat
    Salin, Laurence
    Lopes, Nelson
    Sasson, Nissim
    Case, Ryan
    Rascol, Olivier
    LANCET NEUROLOGY, 2024, 23 (05): : 465 - 476
  • [38] Short- and Long-Term Safety of PEG-J Used for Continuous Infusion of Levodopa-Carbidopa Intestinal Gel
    Draganov, Peter
    Epstein, Michael S.
    Hawes, Robert
    Johnson, David A.
    Vanagunas, Arvydas
    Robieson, Weining Z.
    Chatamra, Krai
    Benesh, Janet A.
    Eaton, Susan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S652 - S652
  • [39] Short- and Long-Term Safety of PEG-J Used for Continuous Infusion of Levodopa-Carbidopa Intestinal Gel
    Draganov, Peter
    Epstein, Michael
    Hawess, Robert
    Johnson, David
    Vanagunast, Arvydas
    Robieson, Weining
    Chatamra, Krai
    Beneshi, Janet
    Eaton, Susan
    NEUROLOGY, 2016, 86
  • [40] BOUNDLESS: AN ACTIVE-CONTROLLED, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY TRIAL OF CONTINUOUS SUBCUTANEOUS INFUSION OF LEVODOPA/CARBIDOPA WITH ND0612 IN PATIENTS WITH PARKINSON'S DISEASE
    Rascol, O.
    Poewe, W.
    Stocchi, F.
    Yardeni, T.
    Barak, S. Leibman
    Adar, L.
    Rosenfeld, O.
    Olanow, C. W.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E53 - E53
12345